Skip to main content
. 2020 Apr 6;11(14):4037–4046. doi: 10.7150/jca.30360

Table 1.

Plasma levels of exo-hsa_circRNA_0056616 and clinicopathological features of the cohort examined.

Clinicopathological features n Exo-hsa_circRNA_0056616
M (P25, P75) P-value
Gender
Male 44 0.569 (0.254, 1.102) 0.765
Female 46 0.370 (0.218, 1.237)
Age
< 60.5 y 45 0.467 (0.168, 1.344) 0.869
≥ 60.5 y 45 0.394 (0.274, 0.846)
T stage
T1 / T2 61 0.658 (0.309, 1.476) 0.002
T3 / T4 27 0.282 (0.156, 0.547)
M stage
M0 65 0.658 (0.306, 1.344) 0.004
M1 25 0.288 (0.165, 0.515)
TNM classification
I-II 50 0.830 (0.325, 1.730) 0.001
III-IV 37 0.287 (0.164, 0.380)
Tumor size*
(Maximum diameter of tumor) 33 0.884 (0.423, 1.476) 0.122
< 2.40 cm 33 0.347 (0.283, 1.243)
Anatomical classification
Central 0.438 (0.161, 1.132) 0.205
Surrounding 0.672 (0.309, 1.385)

M: median; P25: 1st quartile (Q1); P75: 3rd quartile (Q3).